Arcus biosciences, inc. reports earnings results for the third quarter ended september 30, 2019

Arcus biosciences, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 23.249 million compared to usd 12.145 million a year ago. net loss was usd 22.352 million compared to usd 10.812 million a year ago. basic loss per share was usd 0.51 compared to usd 0.25 a year ago. for the nine months, operating loss was usd 71.182 million compared to usd 41.375 million a year ago. net loss was usd 68.112 million compared to usd 37.299 million a year ago. basic loss per share was usd 1.56 compared to usd 1.16 a year ago.
RCUS Ratings Summary
RCUS Quant Ranking